Log in
Enquire now
‌

US Patent 10124003 Therapeutic agent for FGFR inhibitor-resistant cancer

Patent 10124003 was granted and assigned to Taiho Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Taiho Pharmaceutical
Taiho Pharmaceutical
0
Date Filed
July 17, 2014
0
Date of Patent
November 13, 2018
0
Patent Application Number
14905047
0
Patent Citations Received
‌
US Patent 11975002 Preparation and composition for treatment of malignant tumors
0
‌
US Patent 11690843 Preparation and composition for treatment of malignant tumors
0
‌
US Patent 11833151 Pharmaceutical composition including sodium alkyl sulfate
0
‌
US Patent 11883404 Preparation and composition for treatment of malignant tumors
0
Patent Inventor Names
Hiroshi Sootome
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10124003
0
Patent Primary Examiner
‌
Dennis Heyer
0

Find more entities like US Patent 10124003 Therapeutic agent for FGFR inhibitor-resistant cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.